This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil

This study has been terminated.
Lothian Health Board
Information provided by:
University of Edinburgh Identifier:
First received: May 15, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted
For reduction of dislocated shoulder, sedation with propofol and remifentanil should give satisfactory operating conditions and pain relief, and significantly reduce the time to full recovery, compared with morphine and midazolam

Condition Intervention
Shoulder Dislocation Drug: Sedation with propofol and remifentanil

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil

Resource links provided by NLM:

Further study details as provided by University of Edinburgh:

Primary Outcome Measures:
  • Time to full recovery

Secondary Outcome Measures:
  • Operating conditions
  • Pain or discomfort

Estimated Enrollment: 40
Study Start Date: July 2003
Estimated Study Completion Date: June 2005
Detailed Description:
Propofol is a recognised agent for sedation and remifentanil is a short acting opioid analgesic. We intend to provide sedation with propofol, 0.5 mg/Kg, and analgesia with remifentanil 0.5 microgram/Kg for reduction of dislocated shoulders. This will be a randomised sex-stratified comparison with current therapy which is midazolam incrementally up to a maximum of 0.15 mg/Kg, and morphine incrementally up to 0.15 mg/Kg. The primary outcome measure is time to full recovery. Secondary aspects are pain or discomfort during the procedure and operating conditions.

Ages Eligible for Study:   16 Years to 65 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

- Anterior dislocation of the shoulder suitable for manual reduction

Exclusion Criteria:

  • significant other illness
  • body weight 25% greater than expected
  • fear of oxygen masks
  • alcohol intoxication
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00326352

United Kingdom
Royal Infirmary
Edinburgh, Midlothian, United Kingdom, EH16 4HA
Sponsors and Collaborators
University of Edinburgh
Lothian Health Board
Principal Investigator: Gordon B Drummond, FRCA University of Edinburgh
  More Information

Publications: Identifier: NCT00326352     History of Changes
Other Study ID Numbers: 2003/1/13
Study First Received: May 15, 2006
Last Updated: May 15, 2006

Keywords provided by University of Edinburgh:

Additional relevant MeSH terms:
Shoulder Dislocation
Wounds and Injuries
Arm Injuries
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Intravenous
Anesthetics, General
Analgesics, Opioid
Sensory System Agents
Peripheral Nervous System Agents
Adjuvants, Anesthesia
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action processed this record on September 21, 2017